 Participants will have up to four study visits, a screening visit visit 1, a baseline visit 2, a month 3 visit visit 3 and a month 6 or flare visit visit 3 and up to two follow-up phone calls from the study coordinator at randomization and at month 1 randomization and 1 month phone call may be combined if randomization occurs at month 1. 